Logo
    Search

    drug_approvals

    Explore "drug_approvals" with insightful episodes like "FDA Approves Aducanumab — A Controversial Drug For Alzheimer's" and "E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more" from podcasts like ""Short Wave" and "All-In with Chamath, Jason, Sacks & Friedberg"" and more!

    Episodes (2)

    FDA Approves Aducanumab — A Controversial Drug For Alzheimer's

    FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
    The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it.

    For more of Jon's reporting, read "For Those Facing Alzheimer's, A Controversial Drug Offers Hope."

    You can email Short Wave at ShortWave@NPR.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy

    E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more

    E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more

    Follow the besties:

    https://twitter.com/chamath

    https://linktr.ee/calacanis

    https://twitter.com/DavidSacks

    https://twitter.com/friedberg

    Follow the pod:

    https://twitter.com/theallinpod

    https://linktr.ee/allinpodcast

    Show Notes:

    0:00 Bestie intro, Chamath's whereabouts

    2:54 Breaking down Biogen's Alzheimer's drug & the FDA's controversial approval

    26:46 Billionaire space race: Is Bezos going to space too risky or a smart marketing move? How the space industry is a perfect example of effective government intervention. Can anyone dominate space?

    42:55 Big Tech getting back to the office: what is the new normal for companies with thousands of employees?

    56:49 Recent factors on the commercial & private real estate markets, inflation head fake

    1:05:01 ProPublica's report on billionaire tax returns

    1:15:58 Bitcoin toxicity, Snowflake's CEO apologizes for comments on merit & diversity

    1:32:48 Science corner with Friedberg: Induced pluripotent stem cells & cloning

    Intro Music Credit:

    https://rb.gy/tppkzl

    https://twitter.com/yung_spielburg

    Referenced in the show:

    https://www.statnews.com/2021/06/07/fda-grants-historicapproval-to-alzheimers-drug-designed-to-slow-cognitive-decline/

    https://www.bloomberg.com/news/articles/2021-06-10/harvard-expert-quits-fda-panel-as-furor-over-biogen-drug-grows

    https://www.instagram.com/p/CP0MSOqnYEo

    https://www.wsj.com/articles/facebook-lets-more-employees-choose-full-time-remote-work-or-return-to-the-office-11623258049

    https://news.yahoo.com/salesforce-ceo-marc-benioff-on-slack-acquisition-135151402.html

    https://socketsite.com/archives/2021/04/visualizing-all-the-vacant-office-space-in-san-francisco.html

    https://www.wsj.com/articles/if-you-sell-a-house-these-days-the-buyer-might-be-a-pension-fund-11617544801

    https://fred.stlouisfed.org/series/T10YIE

    https://www.propublica.org/article/the-secret-irs-files-trove-of-never-before-seen-records-reveal-how-the-wealthiest-avoid-income-tax

    https://www.aqr.com/Insights/Research/Journal-Article/Buffetts-Alpha

    https://www.ft.com/content/42daca9e-facc-11e7-9bfc-052cbba03425

    https://www.bloomberg.com/news/articles/2021-06-07/snowflake-ceo-offers-apologies-support-for-hiring-diversity

    Tweets:

    https://twitter.com/Jason/status/1401938511826067457

    https://twitter.com/elonmusk/status/1386825367948644352

    https://twitter.com/micsolana/status/1403394491143315456

    https://twitter.com/Jason/status/140302318070958080